Life Sciences Transformational R&D Investment Fund (TRIF) Pilot

Department for Science, Innovation and Technology

Capital grants of £5 million to £25 million for large-scale R&D projects in the UK life sciences sector. Projects must exceed £100 million in total costs and focus on innovation or health resilience with potential economic benefits.

Vem kan ansöka

UK-registered wholly private sector businesses that are product developers, CDMOs, or generics manufacturers, with projects located in the UK, costing at least £100 million total, primarily capital investments, and dependent on the grant to proceed.

Källor

Länkar som AI använde för att samla information om detta bidrag.

Finansiering

£5.0m – £25.0m

Deadline

31 mars 2028

Öppnar

25 september 2025

Arrangörens webbplats Visa källa

Registrera dig för att få matchningar till bidrag som detta automatiskt.

Kom igång gratis

Behörighetskriterier

Be a UK-registered and wholly private sector business.
Operate as a product developer, contract development and manufacturing organisation (CDMO), or generics manufacturer.
Provide two years of audited accounts for the applicant company or parent entity. If unavailable, you must demonstrate that the remaining project funding has been secured.
Show a track record of successfully developing or manufacturing medicines or medical devices, either in the UK or internationally.
Your R&D project must have a total cost (including eligible capital and non-capital costs) of at least £100m.
Be located in the UK.
Be primarily a capital investment.
Be a single company investment (as opposed to forming a partnership between companies or other types of organisations).

Life Sciences Transformational R&D Investment Fund (TRIF) Pilot

Källor

Similar grants